A Study to Evaluate the Safety and Efficacy of RQC for AMD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
To evaluate the safety and efficacy of resveratrol, quercetin, and curcumin in combination (RQC) over 2 years in patients with age-related macular degeneration (AMD).
Epistemonikos ID: c90e19598a8c788be08ea4e2ac7c972ed82321ee
First added on: May 09, 2024